The prognostic value of thyroid-stimulating immunoglobulin in the management of Graves’ disease [PDF]
Background: The bioassay of thyroid-stimulating immunoglobulin was reported to have a similar performance to the commonly used thyroid-stimulating hormone binding inhibition assay, also known as thyroid receptor antibody assay. The normal reference range
Yulin Zhou, Yicheng Qi, Weiqing Wang
exaly +7 more sources
Analytical validation of a novel bioassay for thyroid-stimulating immunoglobulin [PDF]
BackgroundA novel and rapid cell-based bioassay, Turbo TSI, for measurement of thyroid-stimulating immunoglobulins (TSI) was recently reported. An assessment of the analytical performance of this TSI bioassay is described herein.MethodsThawed cells from ...
Paul D Olivo +2 more
exaly +6 more sources
Association of clinical course with thyroid-stimulating immunoglobulin in Graves’ ophthalmopathy in Mongolians [PDF]
Graves' ophthalmopathy (GO) is a complex inflammatory condition affecting the orbit and is often associated with Graves' disease (GD). This study aims to determine the levels of thyroid-stimulating immunoglobulin (TSI) and thyroid-stimulating hormone ...
Sarantuya Jav
exaly +4 more sources
The Early Changes in Thyroid-Stimulating Immunoglobulin Bioassay over Anti-Thyroid Drug Treatment Could Predict Prognosis of Graves’ Disease [PDF]
Background To determine whether baseline thyroid-stimulating immunoglobulin (TSI) bioassay or its early response upon treatment with an anti-thyroid drug (ATD) can predict prognosis of Graves’ disease (GD) in real-world practice.
Jin Yu +8 more
doaj +4 more sources
Role of Maternal Thyroid-Stimulating Immunoglobulin in Graves' Disease for Predicting Perinatal Thyroid Dysfunction [PDF]
Objective To assess maternal thyroid-stimulating immunoglobulin (TSI) as a predictor of neonatal thyroid hyperthyroidism in pregnancies complicated by Graves' disease.
Yiwen Cui, Asha Rijhsinghani
doaj +4 more sources
Agoitrous Graves’ Hyperthyroidism with Markedly Elevated Thyroid Stimulating Immunoglobulin Titre displaying Rapid Response to Carbimazole with Discordant Thyroid Function [PDF]
We characterize the clinical and laboratory characteristics of 5 patients with Graves’ thyrotoxicosis whose serum free thyroxine (fT4) concentration decreased unexpectedly to low levels on conventional doses of carbimazole (CMZ) therapy. The initial fT4
Yin Chian Kon +4 more
doaj +4 more sources
Prognostic factors for thyroid-stimulating immunoglobulin normalization in moderate-to-severe Graves’ orbitopathy: a 36-month longitudinal study [PDF]
Purpose The primary objective of this study was to identify predictive factors linked to the normalization of thyroid-stimulating immunoglobulin (TSI) levels in patients diagnosed with active, moderate-to-severe Graves’ orbitopathy (GO).
Jungyul Park +4 more
doaj +4 more sources
Evaluation of the diagnostic performance of thyroid‐stimulating immunoglobulin and thyrotropin receptor antibodies for Graves' disease [PDF]
Wenqi Shao, Baishen Pan, Beili Wang
exaly +4 more sources
Longitudinal association of thyroid-stimulating immunoglobulin levels with clinical characteristics in thyroid eye disease [PDF]
Objectives The clinical course of thyroid eye disease (TED) is heterogeneous and predicting patients who may develop the severe sequelae of the disease is difficult.
+16 more
doaj +2 more sources
Epidemiology of thyroid-stimulating immunoglobulin in recent-onset symptomatic thyroid eye disease [PDF]
Purpose: This study aims to report correlations between thyroid-stimulating immunoglobulin (TSI) and both clinical and radiological parameters in recent-onset symptomatic thyroid eye disease (TED) patients.
Kenneth Ka Hei Lai +15 more
doaj +2 more sources

